Skip to content

Waldenström's Macroglobulinaemia in Adult Patients Who Have Received At Least One Prior Therapy

The medicines shown here belong to the Oncology Support category and are used for managing Waldenström’s Macroglobulinaemia in Adult Patients Who Have Received At Least One Prior Therapy. Products containing Ibrutinib feature in this group.

Ibrutinib Capsules

Ibrutinib

140mg

Treats certain blood cancers by blocking Bruton's tyrosine kinase, a protein essential for b-cell cancer cell survival and proliferation, resulting to reduced tumour burden.

From$23.83/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.